Abeona Therapeutics (ABEO) Retained Earnings (2010 - 2026)

Abeona Therapeutics' Retained Earnings history runs 17 years deep, the most recent figure standing at $903.5 million for Q1 2026.

• On a quarterly basis, Retained Earnings rose 209.48% year-over-year to $903.5 million in Q1 2026; TTM through Mar 2026 was $903.5 million, a 209.48% increase from a year earlier, with the FY2025 full-year figure at $138000.0, down 99.98% from the prior year.
• Retained Earnings improved to $903.5 million in Q1 2026 per ABEO's latest filing, from $138000.0 in the prior quarter.
• Across five years, Retained Earnings topped out at $903.5 million in Q1 2026 and bottomed at -$825.3 million in Q1 2025.
• The 5-year median for Retained Earnings is $138000.0 (2025), against an average of $91.7 million.
• Across the five-year window, Retained Earnings soared 218.87% in 2022 and slumped 811985.86% in 2024, its largest moves.
• Year by year, Retained Earnings stood at -$695.3 million in 2022, then jumped by 209.9% to $764.2 million in 2023, then grew by 12.13% to $856.8 million in 2024, then slumped by 99.98% to $138000.0 in 2025, then soared by 654640.58% to $903.5 million in 2026.
• Per Business Quant, the three latest ABEO Retained Earnings figures stand at $903.5 million (Q1 2026), $138000.0 (Q4 2025), and -$721.6 million (Q3 2025).